Search results for E1

WEEV Spike glycoprotein E1 ELISA Kit, ProteoGenix, KPTX452

Description of WEEV Spike glycoprotein E1 ELISA Kit Introduction to WEEV Spike Glycoprotein E1 ELISA Kit WEEV Spike glycoprotein E1 ELISA Kit is a highly sensitive and specific diagnostic tool used for the detection and quantification of WEEV (Western Equine Encephalitis Virus) Spike glycoprotein E1 in various biological samples. This kit is designed for research use and has the potential to be a valuable therapeutic target in the treatment of WEEV infections. Structure of WEEV Spike Glycoprotein E1 The WEEV Spike glycoprotein E1 is a structural protein that is located on the surface of the virus. It plays a crucial role in the attachment and entry of the virus into host cells. The protein is composed of 423 amino acids and has a molecular weight of approximately 48 kDa. It contains two major domains, the N-terminal domain (NTD) and the C-terminal domain (CTD), which are connected by a flexible linker region. The NTD is responsible for receptor binding, while the CTD is involved in fusion with the host cell membrane. Activity of WEEV Spike Glycoprotein E1 The WEEV Spike glycoprotein E1 is a key player in the pathogenesis of WEEV infections. It is responsible for the initial attachment of the virus to host cells, which is a crucial step in the infection process. The protein binds to specific receptors on the surface of host cells, allowing the virus to enter and replicate within the cell. In addition, the WEEV Spike glycoprotein E1 is also involved in the fusion of the viral and host cell membranes, leading to the release of the viral genetic material into the host cell. Application of WEEV Spike Glycoprotein E1 ELISA Kit The WEEV Spike glycoprotein E1 ELISA Kit has a wide range of applications in both research and clinical settings. It can be used for the detection and quantification of WEEV Spike glycoprotein E1 in various biological samples, such as serum, plasma, and tissue lysates. This kit can be used to monitor the progression of WEEV infections and assess the effectiveness of antiviral therapies. Therapeutic Target for WEEV Infections The WEEV Spike glycoprotein E1 has been identified as a potential therapeutic target for the treatment of WEEV infections. By targeting this protein, it is possible to inhibit the attachment and entry of the virus into host cells, thereby preventing the spread of the infection. In addition, the WEEV Spike glycoprotein E1 ELISA Kit can be used to screen potential antiviral drugs that target this protein, providing a valuable tool for drug discovery and development. Advantages of WEEV Spike Glycoprotein E1 ELISA Kit The WEEV Spike glycoprotein E1 ELISA Kit offers several advantages over other detection methods for WEEV infections. It is highly sensitive and specific, allowing for the accurate quantification of WEEV Spike glycoprotein E1 in various sample types. The kit is also easy to use, with a simple and straightforward protocol that can be completed in a relatively short amount of time. Furthermore, the WEEV Spike glycoprotein E1 ELISA Kit is cost-effective, making it a practical choice for both research and clinical laboratories. In conclusion, the WEEV Spike glycoprotein E1 ELISA Kit is a valuable tool for the detection and quantification of WEEV Spike glycoprotein E1 in various biological samples. Its high sensitivity and specificity, along with its potential as a therapeutic target, make it an essential component in the study and treatment of WEEV infections. With its wide range of applications and advantages, this kit is a valuable asset for researchers and clinicians alike.

PE Anti-Cyclin E1 antibody [EPR194], Abcam, AB319445

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies . How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone.

PE Anti-Cyclin E1 antibody [SP146], Abcam, AB320478

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies . How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone.

Cyclin E1 Antibody (YA3902)(PBS only), MedChemexpress, HY-P84205A

Cyclin E1 Antibody (YA3902) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to Cyclin E1.

Forkhead Box Protein E1 (FOXE1) Antibody, Abbexa, abx015029

Rabbit polyclonal antibody against TTF2 protein. Immunogen region is Internal.

Forkhead Box Protein E1 (FOXE1) Antibody, Abbexa, abx013267

Rabbit polyclonal antibody against TTF2 protein. Immunogen region is N-terminal.

Pyruvate Dehydrogenase E1 alpha Antibody (YA3708), MedChemexpress, HY-P84011

Pyruvate Dehydrogenase E1 alpha Antibody (YA3708) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to Pyruvate Dehydrogenase E1 alpha.

Pyruvate Dehydrogenase E1 alpha Antibody (YA5141), MedChemexpress, HY-P85449

Pyruvate Dehydrogenase E1 alpha Antibody (YA5141) is a Mouse-derived and non-conjugated monoclonal antibody, targeting to Pyruvate Dehydrogenase E1 alpha.

Pyruvate Dehydrogenase E1 alpha Antibody (YA5196), MedChemexpress, HY-P85504

Pyruvate Dehydrogenase E1 alpha Antibody (YA5196) is a Mouse-derived and non-conjugated monoclonal antibody, targeting to Pyruvate Dehydrogenase E1 alpha.

Anti-Estrone/E1 Monoclonal Antibody (1A478), AntibodySystem, MGK61502